Angiographic documentation of the efficacy of... [Thromb Haemost. 2005] - PubMed

Save items

loading

Related citations in PubMed

Review Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. [BioDrugs. 2008]
Review Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
Croom KF, McCormack PL. BioDrugs. 2008; 22(2):121-36.
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. [Thromb Haemost. 1997]
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
Hay CR, Negrier C, Ludlam CA. Thromb Haemost. 1997 Dec; 78(6):1463-7.
Review A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions. [Br J Haematol. 2006]
Review A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
Mittal S, Watson HG. Br J Haematol. 2006 May; 133(4):355-63.
Controlled off-label use of recombinant activated factor VII (NovoSeven) can build evidence base. [Cardiovasc J Afr. 2008]
Controlled off-label use of recombinant activated factor VII (NovoSeven) can build evidence base.
. Cardiovasc J Afr. 2008 Jan-Feb; 19(1):52-4.
Review Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX. [Pharmacoeconomics. 2007]
Review Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
Lyseng-Williamson KA, Plosker GL. Pharmacoeconomics. 2007; 25(12):1007-29.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Angiographic documentation of the efficacy of recombinant activated factor VII (...
Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.
Thromb Haemost. 2005 Dec ;94(6):1327-8.

PubMed
A case-control study of Alzheimer's disease in China.
A case-control study of Alzheimer's disease in China.
Neurology. 1992 Aug ;42(8):1481-8.

PubMed
Atopic eczema: a modern epidemic.
Atopic eczema: a modern epidemic.
Clin Med. 2005 Nov-Dec ;5(6):559-63.

PubMed
Exercise therapy for positional vertigo.
Exercise therapy for positional vertigo.
Neurology. 1992 Aug ;42(8):1441-4.

PubMed
Azithromycin versus penicillin for early syphilis.
Azithromycin versus penicillin for early syphilis.
N Engl J Med. 2006 Jan 12 ;354(2):203-5; author reply 203-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information